Seres Therapeutics, Inc. (MCRB)
8.85
+0.04
(+0.45%)
USD |
NASDAQ |
Apr 07, 16:00
8.85
0.00 (0.00%)
Pre-Market: 20:00
Seres Therapeutics Market Cap : 77.48M for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.766B |
| Alnylam Pharmaceuticals, Inc. | 42.38B |
| Savara, Inc. | 1.183B |
| BioMarin Pharmaceutical, Inc. | 10.81B |
| Imunon, Inc. | 6.620M |
Market Cap Related Metrics
| PE Ratio | 10.98 |
| PS Ratio | 100.81 |
| Price to Book Value | 1.760 |
| Price to Free Cash Flow | 91.95 |
| Price | 8.85 |
| Earnings Yield | 9.11% |
| Normalized PE Ratio | 10.97 |